Von Graefe's sign

From WikiMD's Medical Encyclopedia

Revision as of 19:55, 29 February 2024 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Von Graefe's sign is a clinical sign in ophthalmology that is often associated with Graves' disease, a type of hyperthyroidism. It is named after the German ophthalmologist Albrecht von Graefe who first described it.

Description

Von Graefe's sign is characterized by a lag in the downward movement of the upper eyelid (known as eyelid lag) during downward gaze. This results in an abnormal widening of the palpebral fissure (the space between the upper and lower eyelids) during downward gaze. It is one of the most common signs of Graves' disease, but it can also be seen in other conditions that affect the extraocular muscles.

Pathophysiology

The pathophysiology of Von Graefe's sign is not completely understood. It is believed to be due to an imbalance in the function of the extraocular muscles, specifically the levator palpebrae superioris muscle and the superior rectus muscle. In Graves' disease, these muscles are often affected by the autoimmune process, leading to inflammation and fibrosis. This results in a restriction of the normal movement of the upper eyelid.

Clinical significance

Von Graefe's sign is a useful clinical sign in the diagnosis of Graves' disease. It is one of the earliest signs of the disease and is often present before other symptoms such as exophthalmos (protrusion of the eyes) and goiter (enlargement of the thyroid gland). However, it is not specific for Graves' disease and can be seen in other conditions that affect the extraocular muscles.

See also

References

Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!



Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.